Israel Ben‐Dor

600 total citations
9 papers, 472 citations indexed

About

Israel Ben‐Dor is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Israel Ben‐Dor has authored 9 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Oncology and 2 papers in Genetics. Recurrent topics in Israel Ben‐Dor's work include Amyotrophic Lateral Sclerosis Research (2 papers), Cancer-related Molecular Pathways (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Israel Ben‐Dor is often cited by papers focused on Amyotrophic Lateral Sclerosis Research (2 papers), Cancer-related Molecular Pathways (2 papers) and Neurogenetic and Muscular Disorders Research (2 papers). Israel Ben‐Dor collaborates with scholars based in Israel and United States. Israel Ben‐Dor's co-authors include Benjamin Reubinoff, Irina Brokhman, Oz Pomp, Ronald S. Goldstein, Yosef Shaul, Eithan Galun, Merav Ben‐Yehoyada, Pavel Itsykson, Daniel Goldenberg and Meir Shamay and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and FEBS Letters.

In The Last Decade

Israel Ben‐Dor

9 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Israel Ben‐Dor Israel 8 304 88 69 63 60 9 472
Antje Arnold United States 14 251 0.8× 49 0.6× 76 1.1× 108 1.7× 36 0.6× 24 482
Zulekha A. Qadeer United States 8 497 1.6× 34 0.4× 39 0.6× 67 1.1× 56 0.9× 8 621
Shinya Obayashi Japan 6 327 1.1× 50 0.6× 61 0.9× 35 0.6× 51 0.8× 8 462
Flavia Troglio Italy 15 325 1.1× 38 0.4× 31 0.4× 33 0.5× 34 0.6× 17 500
Sonia Guidato United Kingdom 9 464 1.5× 43 0.5× 105 1.5× 22 0.3× 43 0.7× 10 605
Elisa Ridolfi Italy 14 525 1.7× 100 1.1× 39 0.6× 23 0.4× 89 1.5× 18 779
Melissa M. Fraser United States 7 272 0.9× 107 1.2× 28 0.4× 169 2.7× 55 0.9× 7 464
Dáša Doležalová Czechia 9 442 1.5× 25 0.3× 82 1.2× 53 0.8× 39 0.7× 10 573
Beng-Ti Ang Singapore 11 390 1.3× 65 0.7× 90 1.3× 76 1.2× 13 0.2× 14 611
Daniel Haag Germany 12 572 1.9× 27 0.3× 141 2.0× 76 1.2× 46 0.8× 15 791

Countries citing papers authored by Israel Ben‐Dor

Since Specialization
Citations

This map shows the geographic impact of Israel Ben‐Dor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Israel Ben‐Dor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Israel Ben‐Dor more than expected).

Fields of papers citing papers by Israel Ben‐Dor

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Israel Ben‐Dor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Israel Ben‐Dor. The network helps show where Israel Ben‐Dor may publish in the future.

Co-authorship network of co-authors of Israel Ben‐Dor

This figure shows the co-authorship network connecting the top 25 collaborators of Israel Ben‐Dor. A scholar is included among the top collaborators of Israel Ben‐Dor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Israel Ben‐Dor. Israel Ben‐Dor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Ben‐Dor, Israel, Crystal Pacut, Yuval Nevo, Eva L. Feldman, & Benjamin Reubinoff. (2021). Characterization of C9orf72 haplotypes to evaluate the effects of normal and pathological variations on its expression and splicing. PLoS Genetics. 17(3). e1009445–e1009445. 3 indexed citations
2.
Ben‐Dor, Israel, Tikva Turetsky, Yaniv Gil, et al.. (2019). Human iPSC-derived astrocytes from ALS patients with mutated C9ORF72 show increased oxidative stress and neurotoxicity. EBioMedicine. 50. 274–289. 127 indexed citations
3.
Ben‐Dor, Israel, Pavel Itsykson, Daniel Goldenberg, Eithan Galun, & Benjamin Reubinoff. (2006). Lentiviral Vectors Harboring a Dual-Gene System Allow High and Homogeneous Transgene Expression in Selected Polyclonal Human Embryonic Stem Cells. Molecular Therapy. 14(2). 255–267. 48 indexed citations
4.
Pomp, Oz, Irina Brokhman, Israel Ben‐Dor, Benjamin Reubinoff, & Ronald S. Goldstein. (2005). Generation of Peripheral Sensory and Sympathetic Neurons and Neural Crest Cells from Human Embryonic Stem Cells. Stem Cells. 23(7). 923–930. 146 indexed citations
5.
Ben‐Yehoyada, Merav, Israel Ben‐Dor, & Yosef Shaul. (2003). c-Abl Tyrosine Kinase Selectively Regulates p73 Nuclear Matrix Association. Journal of Biological Chemistry. 278(36). 34475–34482. 39 indexed citations
6.
Shamay, Meir, Orr Barak, Gilad Doitsh, Israel Ben‐Dor, & Yosef Shaul. (2002). Hepatitis B Virus pX Interacts with HBXAP, a PHD Finger Protein to Coactivate Transcription. Journal of Biological Chemistry. 277(12). 9982–9988. 50 indexed citations
7.
Ben‐Dor, Israel, et al.. (2000). FER Kinase Activation of Stat3 Is Determined by the N-terminal Sequence. Journal of Biological Chemistry. 275(37). 28902–28910. 27 indexed citations
8.
Orlovsky, Kira, et al.. (2000). N-Terminal Sequences Direct the Autophosphorylation States of the FER Tyrosine Kinases in Vivo. Biochemistry. 39(36). 11084–11091. 15 indexed citations
9.
Ben‐Dor, Israel, et al.. (1998). Tyrosine phosphorylation of the TATA element modulatory factor by the FER nuclear tyrosine kinases. FEBS Letters. 434(3). 339–345. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026